SCHEMBL1035524

SCHEMBL1035524

Cc1c(CCl)sc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.48
GPR3 P46089 1/20 0.44
ALDH1A1 P00352 2/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
PRNP P04156 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
HSD11B1 P28845 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
ROCK1 Q13464 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2388976 0.82 CNR2 (0.46) LOXL2GPR3ALDH1A1TAS1R3TAS1R1
SCHEMBL586085 0.80 GPR3 (0.44) LOXL2GPR3ALDH1A1TAS1R3TAS1R1
SCHEMBL2702753 0.80 LOXL2 (0.63) LOXL2GPR3ALDH1A1TAS1R3TAS1R1
SCHEMBL719251 0.80 GPR3 (0.44) LOXL2GPR3ALDH1A1TAS1R3TAS1R1
SCHEMBL2387916 0.78 CNR2 (0.49) LOXL2GPR3ALDH1A1TAS1R3TAS1R1
SCHEMBL4777418 0.78 CYP2D6 (0.52) LOXL2GPR3ALDH1A1TAS1R3TAS1R1
SCHEMBL2324454 0.78 TAS1R3 (0.45) LOXL2ALDH1A1TAS1R3TAS1R1PRNP
SCHEMBL6481714 0.78 LOXL2 (0.71) LOXL2GPR3ALDH1A1PRNPRXFP1
SCHEMBL7100115 0.77 LOXL2 (0.42) LOXL2GPR3ALDH1A1TAS1R3TAS1R1
SCHEMBL4775813 0.77 LOXL2 (0.42) LOXL2GPR3ALDH1A1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
CN-104672220-B The activator of peroxisome proliferator-activated receptor 日本化学医药株式会社 2017-09-22 CN disclosed
CN-104672220-A Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO 2015-06-03 CN disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD LOXL2 3448/4885GPR3 476/4885ALDH1A1 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.